ENGINEERING A HIGHLY POTENT AND SELECTIVE HNTX-III MUTANT AGAINST THE NAV1.7 SODIUM CHANNEL FOR TREATMENT OF PAIN

被引：0
|
作者：
Zhang, Yunxiao [1 ]
Peng, Dezheng [1 ]
Chen, Minzhi [1 ]
Li, Jiayan [1 ]
Li, Dan [1 ]
Liu, Zhonghua [1 ]
Liang, Songping [1 ]
机构：
[1] Hunan Normal Univ, Natl &Local Joint Engn Lab Anim Peptide Drug Dev, Changsha 410081, Hunan, Peoples R China
来源：
TOXICON | 2019年 / 158卷
关键词：
Nav1.7; HNTX-III; Analgesia; Structure activity relationship;
D O I：
10.1016/j.toxicon.2018.10.195
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
186
引用
收藏
页码：S56 / S57
页数：2
相关论文
共 50 条
  • [21] Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7
    Minett, Michael S.
    Pereira, Vanessa
    Sikandar, Shafaq
    Matsuyama, Ayako
    Lolignier, Stephane
    Kanellopoulos, Alexandros H.
    Mancini, Flavia
    Iannetti, Gian D.
    Bogdanov, Yury D.
    Santana-Varela, Sonia
    Millet, Queensta
    Baskozos, Giorgios
    MacAllister, Raymond
    Cox, James J.
    Zhao, Jing
    Wood, John N.
    NATURE COMMUNICATIONS, 2015, 6
  • [22] Structural basis for severe pain caused by mutations in the voltage sensors of sodium channel NaV1.7
    Wisedchaisri, Goragot
    El-Din, Tamer M. Gamal
    Powell, Natasha M.
    Zheng, Ning
    Catterall, William A.
    JOURNAL OF GENERAL PHYSIOLOGY, 2023, 155 (12):
  • [23] Sodium Channel Nav1.7 Is Essential for Lowering Heat Pain Threshold after Burn Injury
    Shields, Shannon D.
    Cheng, Xiaoyang
    Ueceyler, Nurcan
    Sommer, Claudia
    Dib-Hajj, Sulayman D.
    Waxman, Stephen G.
    JOURNAL OF NEUROSCIENCE, 2012, 32 (32): : 10819 - 10832
  • [24] Discovery of pyrrolo-benzo-1,4-diazines as potent Nav1.7 sodium channel blockers
    Ho, Ginny D.
    Tulshian, Deen
    Bercovici, Ana
    Tan, Zheng
    Hanisak, Jennifer
    Brumfield, Stephanie
    Matasi, Julius
    Heap, Charles R.
    Earley, William G.
    Courneya, Brandy
    Herr, R. Jason
    Zhou, Xiaoping
    Bridal, Terry
    Rindgen, Diane
    Sorota, Steve
    Yang, Shu-Wei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (17) : 4110 - 4113
  • [25] Discovery of pyrrolo-benzo-1,4-diazines as potent Nav1.7 sodium channel blockers
    Ho, Ginny D.
    Tulshian, Deen
    Bercovici, Ana
    Tan, Zheng
    Hanisak, Jennifer
    Cooke, Stephanie
    Matasi, Julius
    Heap, Charles R.
    Earley, William G.
    Courneya, Brandy
    Zhou, Xiaoping
    Bridal, Terry
    Rindgen, Diane
    Hyde, Lynn
    Cohen-Williams, Mary
    Sorota, Steve
    Yang, Shu-Wei
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [26] Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model
    Pero, Joseph E.
    Rossi, Michael A.
    Lehman, Hannah D. G. F.
    Kelly, Michael J., III
    Mulhearn, James J.
    Wolkenberg, Scott E.
    Cato, Matthew J.
    Clements, Michelle K.
    Daley, Christopher J.
    Filzen, Tracey
    Finger, Eleftheria N.
    Gregan, Yun
    Henze, Darrell A.
    Jovanovska, Aneta
    Klein, Rebecca
    Kraus, Richard L.
    Li, Yuxing
    Liang, Annie
    Majercak, John M.
    Panigel, Jacqueline
    Urban, Mark O.
    Wang, Jixin
    Wang, Ying-Hong
    Houghton, Andrea K.
    Layton, Mark E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (12) : 2683 - 2688
  • [27] A new Nav1.7 sodium channel mutation I234T in a child with severe pain
    Ahn, Hye-Sook
    Dib-Hajj, Sulayman D.
    Cox, James J.
    Tyrrell, Lynda
    Elmslie, Frances V.
    Clarke, Antonia A.
    Drenth, Joost P. H.
    Woods, Geoffrey
    Waxman, Stephen G.
    EUROPEAN JOURNAL OF PAIN, 2010, 14 (09) : 944 - 950
  • [28] Taking away PAIN: Enabling new structures of the Nav1.7 sodium channel by cryo-EM
    Jao, C.
    Arthur, C.
    Rohou, A.
    Kschonsak, M.
    Ortwine, D.
    Sellers, B.
    Dragovich, P.
    Volgraf, Ma
    Sutherlin, D.
    Koth, C.
    Payanden, J.
    Tellis, J.
    Ciferri, C.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2021, 77 : A16 - A16
  • [29] ProTxII, a selective Nav1.7 sodium channel inhibitor reverses hyperalgesia on mice model of diabetic neuropathy
    Tanaka, Kenichiro
    Nakanishi, Yuki
    Maeda, Kimiko
    Asato, Megumi
    Ikeda, Hiroko
    Kamei, Junzo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 235P - 235P
  • [30] Fluorescent- and tagged-protoxin II peptides: potent markers of the Nav1.7 channel pain target
    Montnach, Jerome
    De Waard, Stephan
    Nicolas, Sebastien
    Burel, Sophie
    Osorio, Nancy
    Zoukimian, Claude
    Mantegazza, Massimo
    Boukaiba, Rachid
    Beroud, Remy
    Partiseti, Michel
    Delmas, Patrick
    Marionneau, Celine
    De Waard, Michel
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (13) : 2632 - 2650
12345